, Le cancer du sein -les cancers les plus fréquents Disponible sur: http://www.e-cancer.fr/Professionnels-de-sante/Les- chiffres-du-cancer-en-France/Epidemiologie-des-cancers/Les-cancers-les-plus-frequents/Cancer- du-sein, Institut National du Cancer, 2018.
Reproductive Factors and Breast Cancer, Epidemiologic Reviews, vol.15, issue.1, pp.36-47, 1993. ,
DOI : 10.1093/oxfordjournals.epirev.a036115
ABC of breast diseases: Breast cancer---epidemiology, risk factors, and genetics, BMJ, vol.321, issue.7261, pp.624-632, 2000. ,
DOI : 10.1136/bmj.321.7261.624
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease, New England Journal of Medicine, vol.312, issue.3, pp.146-51, 1985. ,
DOI : 10.1056/NEJM198501173120303
Institu National du Cancer. Guide-Affection longue durée. Tumeur maligne, affection maligne du tissu lymphatique ou hématopoïétique : cancer du sein, 2010. ,
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update, Journal of Clinical Oncology, vol.31, issue.31, pp.3997-4013, 2013. ,
DOI : 10.1200/JCO.2013.50.9984
Triple-Negative Breast Cancer, New England Journal of Medicine, vol.363, issue.20, 2010. ,
DOI : 10.1056/NEJMra1001389
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype, Cancer, vol.12, issue.9, pp.1721-1729, 2007. ,
DOI : 10.1093/jnci/94.7.490
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study, JAMA, vol.295, issue.21, pp.2492-502, 2006. ,
DOI : 10.1001/jama.295.21.2492
Epidemiology of basal-like breast cancer, Breast Cancer Research and Treatment, vol.315, issue.1 Suppl, pp.123-162, 2008. ,
DOI : 10.1093/jnci/djh025
Epidemiological risk factors associated with inflammatory breast cancer subtypes, Cancer Causes & Control, vol.307, issue.6, pp.359-66, 2016. ,
DOI : 10.1001/jama.2012.39
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence, Clinical Cancer Research, vol.13, issue.15, pp.4429-4463, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-3045
A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors, Cancer Epidemiology Biomarkers & Prevention, vol.14, issue.5, pp.1108-1120, 2005. ,
DOI : 10.1158/1055-9965.EPI-04-0394
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women, Breast Cancer Research and Treatment, vol.61, issue.3, pp.405-415, 2008. ,
DOI : 10.1259/bjr.73.871.11089459
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters, Cancer, vol.47, issue.5, pp.995-1000, 2008. ,
DOI : 10.1002/cncr.23226
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype, Clinical Cancer Research, vol.14, issue.5, pp.1368-76, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-1658
Triple-negative breast cancer: epidemiological considerations and recommendations, Annals of Oncology, vol.15, issue.8, pp.7-12, 2012. ,
DOI : 10.1038/nm0809-842
URL : https://hal.archives-ouvertes.fr/hal-01262979
Basal-Like Breast Cancer: A Critical Review, Journal of Clinical Oncology, vol.26, issue.15, pp.2568-81, 2008. ,
DOI : 10.1200/JCO.2007.13.1748
Identification of basal-like carcinomas in clinical practice: « triple zero/BRCA1-like » carcinomas], Bull Cancer, vol.97, issue.3, pp.357-63, 2010. ,
Typical medullary breast carcinomas have a basal/myoepithelial phenotype, The Journal of Pathology, vol.10, issue.3, pp.260-268, 2005. ,
DOI : 10.1097/01.LAB.0000038508.86221.B3
Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis, Breast Cancer Research and Treatment, vol.25, issue.2, pp.273-80, 2009. ,
DOI : 10.1007/978-3-662-30514-0_3
Identification of molecular apocrine breast tumours by microarray analysis, Oncogene, vol.24, issue.29, pp.4660-71, 2005. ,
DOI : 10.1073/pnas.201162998
URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr1122?site=breast-cancer-research.biomedcentral.com
Integrated Profiling of Basal and Luminal Breast Cancers, Cancer Research, vol.67, issue.24, pp.11565-75, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-2536
The clonal and mutational evolution spectrum of primary triple-negative breast cancers, Nature, vol.464, issue.7403, pp.395-404, 2012. ,
DOI : 10.1038/nature08989
URL : http://europepmc.org/articles/pmc3863681?pdf=render
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.179, issue.1, pp.10869-74, 2001. ,
DOI : 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O
Basal-like breast cancer and the BRCA1 phenotype, Oncogene, vol.25, issue.43, pp.5846-53, 2006. ,
DOI : 10.1073/pnas.171174298
URL : http://www.nature.com/onc/journal/v25/n43/pdf/1209876a.pdf
BRCA1 dysfunction in sporadic basal-like breast cancer, Oncogene, vol.24, issue.14, pp.2126-2158, 2007. ,
DOI : 10.1038/sj.onc.1208538
URL : http://www.nature.com/onc/journal/v26/n14/pdf/1210014a.pdf
Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer, Clinical Cancer Research, vol.17, issue.5, pp.1082-1091, 2011. ,
DOI : 10.1158/1078-0432.CCR-10-2560
URL : http://clincancerres.aacrjournals.org/content/clincanres/17/5/1082.full.pdf
Relationship Between Molecular Subtype of Invasive Breast Carcinoma and Expression of Gross Cystic Disease Fluid Protein 15 and Mammaglobin, American Journal of Clinical Pathology, vol.135, issue.4, pp.587-91, 2011. ,
DOI : 10.1097/PAS.0b013e31817f9790
GATA3 expression in triple-negative breast cancers, Histopathology, vol.6, issue.1, pp.63-71, 2017. ,
DOI : 10.1186/1471-2407-6-96
GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas, Human Pathology, vol.44, issue.7, pp.1341-1350, 2013. ,
DOI : 10.1016/j.humpath.2012.11.003
URL : http://europepmc.org/articles/pmc3991123?pdf=render
Immunohistochemical Evaluation of GATA-3 Expression in ER-Negative Breast Carcinomas, American Journal of Clinical Pathology, vol.25, issue.S2, pp.648-55, 2014. ,
DOI : 10.1309/AJCP0Q9UQTEESLHN
URL : https://academic.oup.com/ajcp/article-pdf/141/5/648/4991393/ajcpath141-0648.pdf
Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer, Human Pathology, vol.45, issue.11, pp.2225-2257, 2014. ,
DOI : 10.1016/j.humpath.2014.06.022
A New Gene Expression Signature for Triple-Negative Breast Cancer Using Frozen Fresh Tissue before Neoadjuvant Chemotherapy, Molecular Medicine, vol.23, issue.1, 2017. ,
DOI : 10.2119/molmed.2016.00257
URL : https://doi.org/10.2119/molmed.2016.00257
A clinically relevant gene signature in triple negative and basal-like breast cancer, Breast Cancer Research, vol.54, issue.5, p.97, 2011. ,
DOI : 10.1002/jcb.240540406
URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3035?site=breast-cancer-research.biomedcentral.com
Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis, International Journal of Oncology, vol.42, issue.2, pp.478-506, 2013. ,
DOI : 10.3892/ijo.2012.1744
Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer, p.100, 2014. ,
Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer, PLoS ONE, vol.411, issue.2, p.55910, 2013. ,
DOI : 10.1371/journal.pone.0055910.s009
URL : https://doi.org/10.1371/journal.pone.0055910
Sox10: A Pan-Schwannian and Melanocytic Marker, The American Journal of Surgical Pathology, vol.32, issue.9, pp.1291-1299, 2008. ,
DOI : 10.1097/PAS.0b013e3181658c14
The importance of having your SOX on: role of SOX10??? in the development of neural crest-derived melanocytes and glia, Oncogene, vol.22, issue.20, pp.3024-3058, 2003. ,
DOI : 10.1016/S0896-6273(00)80898-3
Sorting outSox10 functions in neural crest development, BioEssays, vol.10, issue.8, pp.788-98, 2006. ,
DOI : 10.1017/CBO9780511525322
Peroxisome-proliferator-activated receptor-binding protein (PBP) is essential for the growth of active Notch4-immortalized mammary epithelial cells by activating SOX10 expression, Biochemical Journal, vol.1, issue.2, pp.435-479, 2009. ,
DOI : 10.1128/MCB.00967-07
Notch Signaling: Cell Fate Control and Signal Integration in Development, Science, vol.284, issue.5415, pp.770-776, 1999. ,
DOI : 10.1126/science.284.5415.770
SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cells, Biochemical and Biophysical Research Communications, vol.485, issue.2, pp.522-530, 2017. ,
DOI : 10.1016/j.bbrc.2017.02.014
Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas, British Journal of Cancer, vol.109, issue.2, pp.444-51, 2013. ,
DOI : 10.1074/jbc.M110.149658
URL : http://www.nature.com/bjc/journal/v109/n2/pdf/bjc2013326a.pdf
Sox10???A Marker for Not Only Schwannian and Melanocytic Neoplasms But Also Myoepithelial Cell Tumors of Soft Tissue, The American Journal of Surgical Pathology, vol.39, issue.6, pp.826-861, 2015. ,
DOI : 10.1097/PAS.0000000000000398
Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas, Human Pathology, vol.44, issue.6, pp.959-65, 2013. ,
DOI : 10.1016/j.humpath.2012.09.005
URL : http://europepmc.org/articles/pmc3978178?pdf=render
, Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells. Cell Rep. 29 sept, vol.12, issue.12, pp.2035-2083, 2015.
Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy, SpringerPlus, vol.2, issue.1, p.695, 2013. ,
DOI : 10.1007/s00428-004-1164-4
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation, Nature Cell Biology, vol.98, issue.2, pp.201-210, 2007. ,
DOI : 10.1073/pnas.251547698
AR Signaling in Breast Cancer, Cancers, vol.6, issue.12, 2017. ,
DOI : 10.1186/bcr577
AR-Signaling in Human Malignancies: Prostate Cancer and Beyond, Cancers, vol.11, issue.12, 2017. ,
DOI : 10.1002/hed.23383
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex, Oncotarget, vol.7, issue.50, pp.82648-57, 2016. ,
DOI : 10.18632/oncotarget.12244
, Institut National du cancer -les chiffres du cancer en France - Epidémiologie des cancers -Les cancers les plus fréquents -le cancer du poumon, Institut National du Cancer
Epidemiologie-des-cancers/Les-cancers-les-plus-frequents/Cancer-du-poumon ,
Lung Cancer: Epidemiology, Etiology, and Prevention, Clinics in Chest Medicine, vol.32, issue.4, pp.605-649, 2011. ,
DOI : 10.1016/j.ccm.2011.09.001
, SEER Cancer Statistics Review National Cancer Institute. Bethesda, MD [Internet]. SEER Cancer Statistics Review, 1975.
Triple-Negative Breast Cancer, New England Journal of Medicine, vol.363, issue.20, pp.1938-1986, 2010. ,
DOI : 10.1056/NEJMra1001389
Biomarkers of residual disease after neoadjuvant therapy for breast cancer, Nature Reviews Clinical Oncology, vol.22, issue.8, pp.487-503, 2016. ,
DOI : 10.1016/j.ejca.2014.11.018
Biologic markers determine both the risk and the timing of recurrence in breast cancer, Breast Cancer Research and Treatment, vol.55, issue.4, pp.607-623, 2011. ,
DOI : 10.1200/JCO.2005.06.178
Triple-negative breast cancer: epidemiological considerations and recommendations, Annals of Oncology, vol.15, issue.8, pp.7-12, 2012. ,
DOI : 10.1038/nm0809-842
URL : https://hal.archives-ouvertes.fr/hal-01262979
Pattern of metastatic spread in triple-negative breast cancer, Breast Cancer Research and Treatment, vol.356, issue.2, pp.423-431, 2009. ,
DOI : 10.1093/jnci/djg050
Second Primary Cancers Following Breast Cancer in the Japanese Female Population, Japanese Journal of Cancer Research, vol.56, issue.1, pp.1-8, 2001. ,
DOI : 10.1093/jnci/89.3.227
Incidence of second primary cancers in three Italian population-based cancer registries, European Journal of Cancer, vol.33, issue.11, pp.1829-1863, 1997. ,
DOI : 10.1016/S0959-8049(97)00173-1
Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England, British Journal of Cancer, vol.84, issue.3, pp.435-475, 2001. ,
DOI : 10.1054/bjoc.2000.1603
Risk of New Primary Nonbreast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study, Journal of Clinical Oncology, vol.26, issue.8, pp.1239-1285, 2008. ,
DOI : 10.1200/JCO.2007.11.9081
Risk of second cancer among women with breast cancer, International Journal of Cancer, vol.111, issue.9, pp.2285-92, 2006. ,
DOI : 10.1111/j.1349-7006.2001.tb01040.x
Napsin A, a New Marker for Lung Adenocarcinoma, Is Complementary and More Sensitive and Specific Than Thyroid Transcription Factor 1 in the Differential Diagnosis of Primary Pulmonary Carcinoma: Evaluation of 1674 Cases by Tissue Microarray, Archives of Pathology & Laboratory Medicine, vol.136, issue.2, pp.163-71, 2012. ,
DOI : 10.5858/arpa.2011-0320-OA
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma, Human Pathology, vol.41, issue.1, pp.20-25, 2010. ,
DOI : 10.1016/j.humpath.2009.06.014
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, Journal of Clinical Investigation, vol.121, issue.7, 2011. ,
DOI : 10.1172/JCI45014DS1
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res, pp.1688-98, 2015. ,
DOI : 10.1158/1078-0432.ccr-14-0432
URL : http://clincancerres.aacrjournals.org/content/21/7/1688.full.pdf
Comprehensive molecular portraits of human breast tumours, Nature, vol.16, issue.7418, pp.61-70, 2012. ,
DOI : 10.1016/j.ccr.2009.06.006
GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors, Annals of Diagnostic Pathology, vol.26, pp.20171-20176 ,
DOI : 10.1016/j.anndiagpath.2016.09.011
Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer, Histopathology, vol.50, issue.2, pp.267-74, 2013. ,
DOI : 10.1007/BF02967653
Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes, Journal of Clinical Pathology, vol.45, issue.11, pp.926-960, 2017. ,
DOI : 10.1136/jclinpath-2016-204137
Mammaglobin vs GCDFP-15, American Journal of Clinical Pathology, vol.127, issue.1, pp.103-116, 2007. ,
DOI : 10.1309/TDP92PQLDE2HLEET
URL : https://academic.oup.com/ajcp/article-pdf/127/1/103/24984749/ajcpath127-0103.pdf
GATA3, The American Journal of Surgical Pathology, vol.38, issue.1, pp.13-22, 2014. ,
DOI : 10.1097/PAS.0b013e3182a0218f
Relationship Between Molecular Subtype of Invasive Breast Carcinoma and Expression of Gross Cystic Disease Fluid Protein 15 and Mammaglobin, American Journal of Clinical Pathology, vol.135, issue.4, pp.587-91, 2011. ,
DOI : 10.1097/PAS.0b013e31817f9790
GATA3 expression in triple-negative breast cancers, Histopathology, vol.6, issue.1, pp.63-71 ,
DOI : 10.1186/1471-2407-6-96
GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas, Human Pathology, vol.44, issue.7, 2013. ,
DOI : 10.1016/j.humpath.2012.11.003
Immunohistochemical Evaluation of GATA-3 Expression in ER-Negative Breast Carcinomas, American Journal of Clinical Pathology, vol.25, issue.S2, pp.648-55, 2014. ,
DOI : 10.1309/AJCP0Q9UQTEESLHN
Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer, Human Pathology, vol.45, issue.11, pp.2225-2257, 2014. ,
DOI : 10.1016/j.humpath.2014.06.022
Targeting the androgen receptor in triple-negative breast cancer: current perspectives, OncoTargets and Therapy, vol.10, pp.4675-85, 2017. ,
DOI : 10.2147/OTT.S126051
Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers. Clin Breast Cancer, pp.298-306, 2017. ,
Identification of molecular apocrine breast tumours by microarray analysis. Oncogene, Jul, vol.724, issue.29, pp.4660-71, 2005. ,
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update, Journal of Clinical Oncology, vol.31, issue.31, pp.3997-4013, 2013. ,
DOI : 10.1200/JCO.2013.50.9984
Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res, Feb, vol.1549, issue.4, pp.1052-1058, 1989. ,
WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. WHO Classification of Tumours, International Agency for Research on Cancer, vol.7, 2015. ,
TNM Classification of Malignant Tumors, Eighth edition, 2017. ,
Ionizing Radiation and Tobacco Use Increases the Risk of a Subsequent Lung Carcinoma in Women With Breast Cancer: Case-Only Design, Journal of Clinical Oncology, vol.23, issue.30, pp.7467-74, 2005. ,
DOI : 10.1200/JCO.2005.01.7335
The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status, Cancer Causes & Control, vol.171, issue.2, pp.1721-1729, 2012. ,
DOI : 10.1001/archinternmed.2010.503
Lung Cancer Risk and Radiation Dose Among Women Treated for Breast Cancer, JNCI Journal of the National Cancer Institute, vol.86, issue.13, pp.983-991, 1994. ,
DOI : 10.1093/jnci/86.13.983
Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients, Radiotherapy and Oncology, vol.121, issue.3, 2016. ,
DOI : 10.1016/j.radonc.2016.08.017
Risks of second malignancies after breast cancer treatment: Long-term results. Cancer/Radiothérapie, Feb, vol.21, issue.1, pp.10-15, 2017. ,
Coordinate Expression of Cytokeratins 7 and 20 Defines Unique Subsets of Carcinomas. Appl Immunohistochem, Jul, vol.13, issue.2, pp.99-107, 1995. ,
Molecular portraits of human breast tumours, Nature, vol.278, issue.6797, pp.747-52, 2000. ,
DOI : 10.1038/35000501
How basal are triple-negative breast cancers? Int J Cancer, pp.236-276, 2008. ,
A clinically relevant gene signature in triple negative and basal-like breast cancer, Breast Cancer Research, vol.54, issue.5, p.97, 2011. ,
DOI : 10.1002/jcb.240540406
Biomarkers for Basal-like Breast Cancer, Cancers, vol.119, issue.2, pp.1040-65, 2010. ,
DOI : 10.1158/1078-0432.CCR-08-1208
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, Aug, vol.1510, issue.16, pp.5367-74, 2004. ,
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol, Feb, vol.19, issue.2, pp.264-71, 2006. ,
A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard. Mod Pathol, 2013. ,
The development of the normal human breast, Oxf Rev Reprod Biol, vol.13, pp.149-74, 1991. ,
The Embryology of the Lung, Ciba Foundation Symposium : Development of the Lung, pp.109-139, 1967. ,
DOI : 10.1002/9780470719473.ch7
The importance of having your SOX on: role of SOX10??? in the development of neural crest-derived melanocytes and glia, Oncogene, vol.22, issue.20, pp.3024-3058, 2003. ,
DOI : 10.1016/S0896-6273(00)80898-3
Sorting out Sox10 functions in neural crest development, BioEssays, 2006. ,
Peroxisome-proliferator-activated receptor-binding protein (PBP) is essential for the growth of active Notch4-immortalized mammary epithelial cells by activating SOX10 expression, Biochemical Journal, vol.1, issue.2, pp.435-479, 2009. ,
DOI : 10.1128/MCB.00967-07
SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cells, Biochemical and Biophysical Research Communications, vol.485, issue.2, pp.522-530 ,
DOI : 10.1016/j.bbrc.2017.02.014
Sox10: A Pan-Schwannian and Melanocytic Marker, The American Journal of Surgical Pathology, vol.32, issue.9, pp.1291-1299, 2008. ,
DOI : 10.1097/PAS.0b013e3181658c14
Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas, Human Pathology, vol.44, issue.6, p.2013 ,
DOI : 10.1016/j.humpath.2012.09.005
Sox10???A Marker for Not Only Schwannian and Melanocytic Neoplasms But Also Myoepithelial Cell Tumors of Soft Tissue, The American Journal of Surgical Pathology, vol.39, issue.6, pp.826-861 ,
DOI : 10.1097/PAS.0000000000000398
Utility of Sox10 labeling in metastatic breast carcinomas, Human Pathology, vol.67, pp.205-215 ,
DOI : 10.1016/j.humpath.2017.08.011
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation, Nature Cell Biology, vol.98, issue.2, pp.201-210, 2007. ,
DOI : 10.1073/pnas.251547698
AR Signaling in Breast Cancer, Cancers, vol.6, issue.12 ,
DOI : 10.1186/bcr577
URL : https://www.mdpi.com/2072-6694/9/3/21/pdf
AR-Signaling in Human Malignancies: Prostate Cancer and Beyond, Cancers, vol.11, issue.12, 2017. ,
DOI : 10.1002/hed.23383
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex, Oncotarget, vol.7, issue.50, pp.82648-57, 2016. ,
DOI : 10.18632/oncotarget.12244
Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer, Modern Pathology, vol.55, issue.3, pp.352-60, 2014. ,
DOI : 10.1507/endocrj.K07E-053
Prognostic markers in triple-negative breast cancer, Cancer, vol.91, issue.1, pp.25-32, 2007. ,
DOI : 10.1016/S0002-9440(10)64476-8
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation, Modern Pathology, vol.185, issue.2, pp.205-217, 2010. ,
DOI : 10.1016/S0002-9610(03)00054-0
Expression of androgen receptors in primary breast cancer, Annals of Oncology, vol.25, issue.28, pp.488-92, 2010. ,
DOI : 10.1038/sj.onc.1209415
Androgen Receptor Inhibits Estrogen Receptor-?? Activity and Is Prognostic in Breast Cancer, Cancer Research, vol.69, issue.15, pp.6131-6171, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-0452
Apocrine differentiation in human mammary carcinoma. Cancer, pp.2463-71, 1980. ,
FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer, Cancer Research, vol.70, issue.10, pp.3870-3876, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-4120
A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard, Modern Pathology, vol.52, issue.11, pp.1438-50, 2013. ,
DOI : 10.1093/jnci/djn326